Please type a website descriptionThe global multiplex assays market in terms of revenue was estimated to be worth $3.5 billion in 2022 and is poised to reach $5.3 billion by 2027, growing at a CAGR of 8.8% from 2022 to 2027. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market. The need for automated and efficient systems in laboratories has grown, as conventional methods for testing are inadequate. This provides opportunities for the adoption of multiplex assays, with their potential for automation, convenience, accuracy, and reproducibility. Bead-based microplate assays provide a greater surface area for binding with lower background signals than traditional ELISA, while the beads can be coded and used in multiplex assays, which measure multiple analytes in a single-microplate well to reduce the overall cost and time per assay.
read more..